Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

ClinicalTrials.gov ID: NCT00048763

Public ClinicalTrials.gov record NCT00048763. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00048763
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Otsuka America Pharmaceutical
Industry
Enrollment
75 participants

Conditions and interventions

Interventions

  • Pletal Drug

Drug

Eligibility (public fields only)

Age range
5 Years to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2001
Primary completion
Not listed
Completion
May 31, 2003
Last update posted
Jul 18, 2005

2001 – 2003

United States locations

U.S. sites
18
U.S. states
14
U.S. cities
18
Facility City State ZIP Site status
Advanced Medical Clinical Therapeutics Anchorage Alaska 99508
Advanced Medical Research Institute Fresno California 93710
Madera Family Medical Group Madera California 93637
Connecticut Children's Medical Center Hartford Connecticut 06106
LaRabida Children's Hospital Chicago Illinois 60649
Children's Hospital Boston Boston Massachusetts 02115
St. Louis University Health Sciences Center St Louis Missouri 63104
Children's Hospital Omaha Nebraska 68114
Asthma & Allergy Research Center Newark New Jersey 07103
SUNY Downstate Medical Center Brooklyn New York 11203
Children's Hospital of Buffalo Buffalo New York 14222
Schneider Children's Hospital New Hyde Park New York 11040
New York Medical College Valhalla New York 10595
Jobst Vascular Center Toledo Ohio 43606
The Milton S. Hershey Medical Center Hershey Pennsylvania 17033
Medical University of South Carolina Charleston South Carolina 29425
Monarch Research Associates Norfolk Virginia 23510
Children's Hospital and Regional Medical Center Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00048763, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 18, 2005 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00048763 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →